logo
AAT Bioquest

 
search
logo
AAT Bioquest
Contact us
Company
Telephone:1-408-733-1055
Fax:1-408-733-1304
Hours:Monday to Friday
8:30 - 17:30 PST (GMT-8)
Location:5775 W Las Positas Blvd.
Pleasanton, CA, 94588
USA

Email us
Sales:sales@aatbio.com
Technical Support:support@aatbio.com
Website:websupport@aatbio.com
General Inquiries:info@aatbio.com
Order info
United States of America
Telephone:1-408-733-1055
Fax:1-408-733-1304
Email:sales@aatbio.com
Purchase Order:sales@aatbio.com

International
Click here to see all available distributors
 
search
calculatorCalculator

Vascular endothelial growth factor receptor 3 Inhibitors (IC50, Ki)

Structure
▲
▼
Compound Name
▲
▼
Standard Type
▲
▼
Standard Values (in nM)
▲
▼
StaurosporineIC503.27 [1]
NintedanibIC503.0 [1], 3.2 [2], 5.0 [3], 13.0 [4]
3-(1H-Indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dioneIC505.0 [1], 22.0 [2]
4-[2-[3-(2-Aminoethyl)-1-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]indol-5-yl]oxyethyl]phenolIC502980.0 [1], 3010.0 [2], 3080.0 [3]
4-[2-[[6-Amino-9-(5-phenylpentyl)-5,6,7,8-tetrahydrocarbazol-3-yl]oxy]ethyl]phenolIC502110.0 [1], 2170.0 [2], 2190.0 [3]
DovitinibIC502.51 [1], 3.0 [2], 8.0 [3]
ForetinibIC502.8 [1]
LinifanibIC5012.59 [1], 190.0 [2]
SorafenibIC503.0 [1], 16.0 [2]
SunitinibIC508.9 [1]
SunitinibKi17.0 [1]
PazopanibIC5046.0 [1], 47.0 [2]
VatalanibIC50195.0 [1]
SemaxanibIC5050.0 [1], 500.0 [2]
TivozanibIC500.24 [1], 3.11 [2]
2-(Pyridin-4-Ylmethylamino)-~{n}-[3-(Trifluoromethyl)phenyl]benzamideIC5018.0 [1]
Tak-593IC501.1 [1]
1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)ureaIC5013.0 [1]
(1S)-2-(1H-Indol-3-YL)-1-[({5-[(E)-2-pyridin-4-ylvinyl]pyridin-3-YL}oxy)methyl]ethylamineIC5050000.0 [1]
9-(2,6-Dimethylstyryl)-N-(4-(dimethylphosphoryl)phenyl)-9H-purin-6-amineIC50151.0 [1], 1000.0 [2]
2-[2-[2-[5-Chloro-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]ethyl]phenyl]propanamideIC509.0 [1], 52.0 [2]
2-[2-[2-[5-Chloro-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]ethyl]phenyl]-2-methylpropanamideIC503.0 [1], 23.0 [2]
2-(2-(2-(5-Methyl-2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)ethyl)phenyl)propanamideIC5015.0 [1], 526.0 [2]
2-[2-[2-[2-[(1-Piperidin-4-ylpyrazol-4-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]propanamideIC5027.0 [1], 68.0 [2]
2-[2-[2-[2-[[1-(1-Methylpiperidin-4-yl)pyrazol-4-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]propanamideIC5027.0 [1]
1-[2-[2-[2-[(6-Methoxypyridin-3-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC508.0 [1], 394.0 [2]
2-[2-[2-[2-(4-Piperidin-4-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]butanamideIC5091.0 [1], 173.0 [2]
1-[2-[2-[2-(4-Piperidin-4-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC5010.0 [1], 26.0 [2]
1-[2-[2-[2-[4-(1-Methylpiperidin-4-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC509.0 [1], 27.0 [2]
1-[2-[2-[2-[4-(Azetidin-3-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC5022.0 [1], 38.0 [2]
1-[2-[2-[2-[(6-Piperidin-4-ylpyridin-3-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC5028.0 [1], 51.0 [2]
1-(2-(2-(5-Chloro-2-(pyridin-3-ylamino)pyrimidin-4-yl)ethyl)phenyl)cyclopropanecarboxamideIC508.0 [1], 17.0 [2]
1-[2-[2-[5-Chloro-2-[4-(1-methylpiperidin-4-yl)anilino]pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC5010.0 [1], 19.0 [2]
1-[2-[2-[5-Chloro-2-[[6-(trifluoromethyl)pyridin-3-yl]amino]pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC5075.0 [1], 92.0 [2]
1-(2-(2-(5-Chloro-2-(pyrimidin-5-ylamino)pyrimidin-4-yl)ethyl)phenyl)cyclopropanecarboxamideIC5039.0 [1], 267.0 [2]
1-[2-[2-[5-Chloro-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC504.0 [1], 9.0 [2]
1-[2-[2-[2-[[1-(Azetidin-3-yl)pyrazol-4-yl]amino]-5-chloropyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC506.0 [1], 30.0 [2]
1-[2-[2-[5-Chloro-2-[(6-piperidin-4-ylpyridin-3-yl)amino]pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC5011.0 [1], 51.0 [2]
1-[2-[2-[5-Chloro-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC509.0 [1], 62.0 [2]
1-[2-[2-[5-Chloro-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC503.0 [1], 5.0 [2]
1-(2-(2-(2-(1H-Pyrazol-4-ylamino)-5-chloropyrimidin-4-yl)ethyl)phenyl)cyclopropanecarboxamideIC503.0 [1], 11.0 [2]
1-[2-[2-[5-Chloro-2-[(1-pyrrolidin-3-ylpyrazol-4-yl)amino]pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC507.0 [1], 38.0 [2]
1-[2-[2-[5-Chloro-2-[[1-(1-methylpyrrolidin-3-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC507.0 [1], 14.0 [2]
Tert-butyl N-[1-[4-[[4-[2-[2-(1-carbamoylcyclopropyl)phenyl]ethyl]-5-chloropyrimidin-2-yl]amino]phenyl]ethyl]carbamateIC502.0 [1], 25.0 [2]
2-(2-(2-(2-(1H-Pyrazol-4-ylamino)-5-chloropyrimidin-4-yl)ethyl)phenyl)propanamideIC509.0 [1], 64.0 [2]
2-(2-(5-Chloro-2-(1-methyl-1H-pyrazol-4-ylamino)pyrimidin-4-ylethyl)phenyl)propanamideIC5016.0 [1], 76.0 [2]
1-[2-[2-[5-Chloro-2-(4-piperidin-4-ylanilino)pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC5010.0 [1], 38.0 [2]
(2R)-2-[2-[2-[2-(4-Piperidin-4-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]butanamideIC50103.0 [1], 329.0 [2]
(2S)-2-[2-[2-[2-(4-Piperidin-4-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]butanamideIC5075.0 [1], 315.0 [2]
1-[2-[2-[5-Chloro-2-[[6-(1-methylpiperidin-4-yl)pyridin-3-yl]amino]pyrimidin-4-yl]ethyl]phenyl]cyclopropane-1-carboxamideIC501.0 [1], 4.0 [2]
Ellagic acidIC501540.0 [1]
VandetanibIC50233.0 [1]
AxitinibIC500.1 [1]
Nintedanib esylateIC5013.0 [1]
CediranibIC503.0 [1]
LenvatinibIC505.2 [1]
SaracatinibIC5010000.0 [1]
DoramapimodIC50270.0 [1]
SotrastaurinIC504600.0 [1]
MotesanibIC506.0 [1]
3,9-Bis((ethylthio)methyl)-K-252aIC5039.0 [1]
DanusertibIC50161.0 [1]
Pyridone 6IC50690.0 [1]
EntrectinibIC501000.0 [1]
FilgotinibIC50274.0 [1]
1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)ureaIC501.0 [1]
TelatinibIC504.0 [1]
5-(5,6-Dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamideIC5092.0 [1]
2-(Pyridin-4-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-oneIC5010000.0 [1]
VEGF receptor tyrosine kinase inhibitor IIIIC50125.0 [1]
MilciclibIC50920.0 [1]
3-[4-[4-[2-[3-[(Dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethylpyrazol-3-yl]phenyl]-1,1-dimethylureaIC5074.0 [1]
1-(3-Chlorophenyl)-3-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)ethyl]-1,3-Thiazol-2-Yl}ureaIC5014.0 [1]
Pha-793887IC5010000.0 [1]
LucitanibIC5010.0 [1]
3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamideIC5054.2 [1]
MK-2461IC5078.0 [1]
Serotonin hydrochlorideIC5050000.0 [1]
Cc-223IC50651.0 [1]
N-(3-Chloro-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amineIC502400.0 [1]
(4S,6Z,9S,10S)-9,10,18-Trihydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,15,17-tetraene-2,8-dioneIC501.13 [1]
JNK Inhibitor VIIIKi7100.0 [1]
Nms-P937 (nms1286937)IC5010000.0 [1]
Pyrimidone, 22IC50120.0 [1]
3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[2-fluoro-5-(trifluoromethyl)phenyl]ureaIC507.59 [1]
2-(4-Fluoroanilino)-5-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-3-methylpyrimidin-4-oneIC505.0 [1]
TafetinibIC501.3 [1]
3-(3-Hydroxypropyl)-7-(propan-2-yloxymethyl)-3,13-diazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1(16),2(10),4(9),5,7,11(15),17,19,21-nonaen-14-oneIC504.0 [1]
5-[2,4-Dihydroxy-6-(4-Nitrophenoxy)phenyl]-N-(1-Methylpiperidin-4-Yl)-1,2-Oxazole-3-CarboxamideIC5010.0 [1]
(12E,25E,28E)-5,16,21,32-Tetrabromo-4,20-dihydroxy-12,25-bis(hydroxyimino)-2,18-dioxa-10,27-diazapentacyclo[28.2.2.214,17.13,7.119,23]octatriaconta-1(32),3,5,7(38),14,16,19,21,23(35),28,30,33,36-tridecaene-11,26-dioneIC503200.0 [1]
2-(4-((6,7-Dimethoxyquinazolin-4-yl)oxy)phenyl)-N-(1-isopropyl-1H-pyrazol-4-yl)acetamideIC508.0 [1]
Alsterpaullone, 2-CyanoethylIC501000.0 [1]
N-(4-Chlorophenyl)-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamideIC502.0 [1]
(1S,2S,3R,4R)-3-[[5-Chloro-2-[[(7S)-4-methoxy-7-morpholin-4-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamideIC5048.0 [1]
Flt3-IN-1IC503700.0 [1]
(2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amineIC5050000.0 [1]
CID 118295624IC50410.0 [1]
Unii-BL7xsd8R7BIC50360.0 [1]
8-[2-Methoxy-5-(4-methylpiperazin-1-yl)anilino]-1-methyl-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamideIC50587.0 [1]
N-(3-Cyclopropyl-1H-pyrazol-5-YL)-2-(2-naphthyl)acetamideIC5010000.0 [1]
Items per page: 1 - 10 of 100
⟨⟩

References

This online tool may be cited as follows

MLA

"Quest Database™ Vascular endothelial growth factor receptor 3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/vascular-endothelial-growth-factor-receptor-3-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024, November 21). Quest Database™ Vascular endothelial growth factor receptor 3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/vascular-endothelial-growth-factor-receptor-3-inhibitors-ic50-ki.
BibTeXEndNoteRefMan